Junbin Liao
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- RNA modifications and cancer 6
- Cancer-related gene regulation 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Co-authors
- Sui Peng (12 shared papers)Lixia Xu (8 shared papers)Shuibin Lin (6 shared papers)Zihao Dai (6 shared papers)Zhenwei Peng (8 shared papers)Ming Kuang (5 shared papers)Shenghua Zhu (3 shared papers)Shuling Chen (7 shared papers)
- Journals
- Hepatology (3 papers)Cancer Letters (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Molecular Cell (1 paper)Advanced Healthcare Materials (1 paper)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Junbin Liao
17 papers receiving 1.1k citations
Junbin Liao's Hit Papers
Peers
Comparison fields: 5 of 62
- Cancer Research 310
- Hepatology 136
- Molecular Biology 671
- Oncology 176
- Biotechnology 46
Countries citing papers authored by Junbin Liao
This map shows the geographic impact of Junbin Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbin Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbin Liao more than expected).
Fields of papers citing papers by Junbin Liao
This network shows the impact of papers produced by Junbin Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbin Liao. The network helps show where Junbin Liao may publish in the future.
Co-authors
The 25 scholars most cited alongside Junbin Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression Hit paper breakdown → | 2021 | 213 |
| 2 | 2022 | 146 | |
| 3 | 2021 | 143 | |
| 4 | 2021 | 103 | |
| 5 | 2021 | 65 | |
| 6 | 2018 | 64 | |
| 7 | 2019 | 60 | |
| 8 | 2019 | 49 | |
| 9 | 2022 | 48 | |
| 10 | 2023 | 39 | |
| 11 | 2018 | 32 | |
| 12 | 2023 | 32 | |
| 13 | 2021 | 32 | |
| 14 | 2023 | 31 | |
| 15 | 2023 | 17 | |
| 16 | 2023 | 7 | |
| 17 | 2022 | 3 | |
| 18 | 2019 | 1 | |
| 19 | 2019 | 0 |
About Junbin Liao
Junbin Liao is a scholar working on Molecular Biology, Hepatology, Cancer Research, Surgery and Oncology, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer-related gene regulation (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer Cells and Metastasis (2 papers), Cancer-related molecular mechanisms research (2 papers) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Cancer Research (310 citations), Hepatology (136 citations), Molecular Biology (671 citations), Oncology (176 citations) and Biotechnology (46 citations). Junbin Liao has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Sui Peng, Lixia Xu, Shuibin Lin, Zihao Dai, Zhenwei Peng, Ming Kuang, Shenghua Zhu, Shuling Chen, Ming Kuang and Hai‐Ning Liu. Their work appears in journals such as Hepatology, Cancer Letters, Journal of Experimental & Clinical Cancer Research, Molecular Cell and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.